Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

Statement of Comprehensive Income 

Merck & Co. Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income 17,133 377 14,526 13,062 7,082
Net unrealized income (loss) on derivatives, net of reclassifications 266 (97) (71) 410 (297)
Net unrealized gain (loss) on investments, net of reclassifications (18)
Benefit plan net gain (loss) and prior service credit (cost), net of amortization 466 (385) 335 1,769 (279)
Cumulative translation adjustment (516) 89 (603) (423) 153
Other comprehensive income (loss) net of taxes 216 (393) (339) 1,756 (441)
Comprehensive income (loss) 17,349 (16) 14,187 14,818 6,641
Comprehensive income attributable to noncontrolling interests (16) (12) (7) (13) (15)
Comprehensive income (loss) attributable to Merck & Co., Inc. 17,333 (28) 14,180 14,805 6,626

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Comprehensive income item Description The company
Net income attributable to Merck & Co., Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Merck & Co. Inc. net income attributable to Merck & Co., Inc. decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Comprehensive income (loss) attributable to Merck & Co., Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Merck & Co. Inc. comprehensive income (loss) attributable to Merck & Co., Inc. decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.